Gregory H. Hockerman - Publications

Affiliations: 
Purdue University, West Lafayette, IN, United States 
Area:
Neuroscience Biology, Pharmacology

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Whitmore C, Pratt EPS, Anderson L, Bradley K, Latour SM, Hashmi MN, Urazaev AK, Weilbaecher R, Davie JK, Wang WH, Hockerman GH, Pond AL. The ERG1a potassium channel increases basal intracellular calcium concentration and calpain activity in skeletal muscle cells. Skeletal Muscle. 10: 1. PMID 31948476 DOI: 10.1186/S13395-019-0220-3  0.393
2020 Pond AL, Zampieri S, Sandri M, Cheatwood J, Kohli P, Balaraman R, Anderson LB, Latour CD, Hockerman GH, Kern H, Sartori R, Merigiano S, Da Dalt G, Davie JK, Carraro U. The ERG1 Potassium Channel is Abundant in Cachectic Human Skeletal Muscle The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05573  0.375
2018 Wang Y, Tang S, Harvey KE, Salyer AE, Li TA, Rantz EK, Lill MA, Hockerman GH. Molecular determinants of the differential modulation of Cav1.2 and Cav1.3 by nifedipine and FPL 64176. Molecular Pharmacology. PMID 29980657 DOI: 10.1124/Mol.118.112441  0.392
2016 Pratt EP, Salyer AE, Guerra ML, Hockerman GH. Ca(2+) influx through L-type Ca(2+) channels and Ca(2+)-induced Ca(2+) release regulate cAMP accumulation and Epac1-dependent ERK 1/2 activation in INS-1 cells. Molecular and Cellular Endocrinology. 419: 60-71. PMID 26435461 DOI: 10.1016/J.Mce.2015.09.034  0.39
2014 Hockerman GH, Dethrow NM, Hameed S, Doran M, Jaeger C, Wang WH, Pond AL. The Ubr2 Gene is Expressed in Skeletal Muscle Atrophying as a Result of Hind Limb Suspension, but not Merg1a Expression Alone. European Journal of Translational Myology. 24: 3319. PMID 26913136 DOI: 10.4081/Ejtm.2014.3319  0.355
2014 Wang Y, Jarrard RE, Pratt EP, Guerra ML, Salyer AE, Lange AM, Soderling IM, Hockerman GH. Uncoupling of Cav1.2 from Ca(2+)-induced Ca(2+) release and SK channel regulation in pancreatic β-cells. Molecular Endocrinology (Baltimore, Md.). 28: 458-76. PMID 24506535 DOI: 10.1210/Me.2013-1094  0.371
2014 Pond AL, Nedele C, Wang WH, Wang X, Walther C, Jaeger C, Bradley KS, Du H, Fujita N, Hockerman GH, Hannon KM. The mERG1a channel modulates skeletal muscle MuRF1, but not MAFbx, expression. Muscle & Nerve. 49: 378-88. PMID 23761265 DOI: 10.1002/Mus.23924  0.401
2013 Jarrard RE, Wang Y, Salyer AE, Pratt EP, Soderling IM, Guerra ML, Lange AM, Broderick HJ, Hockerman GH. Potentiation of sulfonylurea action by an EPAC-selective cAMP analog in INS-1 cells: comparison of tolbutamide and gliclazide and a potential role for EPAC activation of a 2-APB-sensitive Ca2+ influx. Molecular Pharmacology. 83: 191-205. PMID 23071106 DOI: 10.1124/Mol.112.081943  0.369
2011 Lin M, Aladejebi O, Hockerman GH. Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive. European Journal of Pharmacology. 670: 105-13. PMID 21910984 DOI: 10.1016/J.Ejphar.2011.08.005  0.391
2009 Jacobo SM, Guerra ML, Hockerman GH. Cav1.2 and Cav1.3 are differentially coupled to glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion in the pancreatic beta-cell line INS-1. The Journal of Pharmacology and Experimental Therapeutics. 331: 724-32. PMID 19710366 DOI: 10.1124/Jpet.109.158519  0.335
2008 Wang X, Xu R, Abernathey G, Taylor J, Alzghoul MB, Hannon K, Hockerman GH, Pond AL. Kv11.1 channel subunit composition includes MinK and varies developmentally in mouse cardiac muscle. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 237: 2430-7. PMID 18729211 DOI: 10.1002/Dvdy.21671  0.353
2007 Walsh KB, Zhang J, Fuseler JW, Hilliard N, Hockerman GH. Adenoviral-mediated expression of dihydropyridine-insensitive L-type calcium channels in cardiac ventricular myocytes and fibroblasts. European Journal of Pharmacology. 565: 7-16. PMID 17397827 DOI: 10.1016/J.Ejphar.2007.02.049  0.435
2006 Wang X, Hockerman GH, Green HW, Babbs CF, Mohammad SI, Gerrard D, Latour MA, London B, Hannon KM, Pond AL. Merg1a K+ channel induces skeletal muscle atrophy by activating the ubiquitin proteasome pathway. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1531-3. PMID 16723379 DOI: 10.1096/Fj.05-5350Fje  0.362
2004 Spelbrink RG, Dilmac N, Allen A, Smith TJ, Shah DM, Hockerman GH. Differential antifungal and calcium channel-blocking activity among structurally related plant defensins. Plant Physiology. 135: 2055-67. PMID 15299136 DOI: 10.1104/Pp.104.040873  0.358
2003 Dilmac N, Hilliard N, Hockerman GH. Molecular determinants of Ca2+ potentiation of diltiazem block and Ca2+-dependent inactivation in the pore region of cav1.2. Molecular Pharmacology. 64: 491-501. PMID 12869655 DOI: 10.1124/Mol.64.2.491  0.316
2002 Gage MJ, Rane SG, Hockerman GH, Smith TJ. The virally encoded fungal toxin KP4 specifically blocks L-type voltage-gated calcium channels. Molecular Pharmacology. 61: 936-44. PMID 11901234 DOI: 10.1124/Mol.61.4.936  0.39
2000 Hockerman GH, Dilmac N, Scheuer T, Catterall WA. Molecular determinants of diltiazem block in domains IIIS6 and IVS6 of L-type Ca(2+) channels. Molecular Pharmacology. 58: 1264-70. PMID 11093762 DOI: 10.1124/Mol.58.6.1264  0.408
1997 Hockerman GH, Peterson BZ, Sharp E, Tanada TN, Scheuer T, Catterall WA. Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by single amino acid substitutions in a non-L-type Ca2+ channel. Proceedings of the National Academy of Sciences of the United States of America. 94: 14906-11. PMID 9405712 DOI: 10.1073/pnas.94.26.14906  0.329
1997 Hockerman GH, Johnson BD, Abbott MR, Scheuer T, Catterall WA. Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels in transmembrane segment IIIS6 and the pore region of the alpha1 subunit. The Journal of Biological Chemistry. 272: 18759-65. PMID 9228049 DOI: 10.1074/jbc.272.30.18759  0.306
1997 Peterson BZ, Johnson BD, Hockerman GH, Acheson M, Scheuer T, Catterall WA. Analysis of the dihydropyridine receptor site of L-type calcium channels by alanine-scanning mutagenesis. The Journal of Biological Chemistry. 272: 18752-8. PMID 9228048 DOI: 10.1074/jbc.272.30.18752  0.324
1997 Hockerman GH, Peterson BZ, Johnson BD, Catterall WA. Molecular determinants of drug binding and action on L-type calcium channels. Annual Review of Pharmacology and Toxicology. 37: 361-96. PMID 9131258 DOI: 10.1146/annurev.pharmtox.37.1.361  0.302
1997 Johnson BD, Brousal JP, Peterson BZ, Gallombardo PA, Hockerman GH, Lai Y, Scheuer T, Catterall WA. Modulation of the cloned skeletal muscle L-type Ca2+ channel by anchored cAMP-dependent protein kinase. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 1243-55. PMID 9006969 DOI: 10.1523/Jneurosci.17-04-01243.1997  0.388
1995 Hockerman GH, Johnson BD, Scheuer T, Catterall WA. Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels. The Journal of Biological Chemistry. 270: 22119-22. PMID 7673189 DOI: 10.1074/jbc.270.38.22119  0.317
Show low-probability matches.